Cargando…
ECTRIMS/EAN consensus on vaccination in people with multiple sclerosis: Improving immunization strategies in the era of highly active immunotherapeutic drugs
BACKGROUND: With the new highly active drugs available for people with multiple sclerosis (pwMS), vaccination becomes an essential part of the risk management strategy OBJECTIVE: To develop a European evidence-based consensus for the vaccination strategy of pwMS who are candidates for disease-modify...
Autores principales: | Otero-Romero, Susana, Lebrun-Frénay, Christine, Reyes, Saúl, Amato, Maria Pia, Campins, Magda, Farez, Mauricio, Filippi, Massimo, Hacohen, Yael, Hemmer, Bernhard, Juuti, Rosa, Magyari, Melinda, Oreja-Guevara, Celia, Siva, Aksel, Vukusic, Sandra, Tintoré, Mar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10338708/ https://www.ncbi.nlm.nih.gov/pubmed/37293841 http://dx.doi.org/10.1177/13524585231168043 |
Ejemplares similares
-
Commentary on the ECTRIMS–EAN guideline for pharmacological treatment of multiple sclerosis
por: Thompson, Alan J.
Publicado: (2018) -
Empfehlungen zur COVID-19-Impfung bei MS -Positionspapier von ECTRIMS und EAN
por: Müller, Thomas
Publicado: (2021) -
XV Reunión Post-ECTRIMS: revisión de las novedades presentadas en el Congreso ECTRIMS 2022 (II)
por: Fernández, Óscar, et al.
Publicado: (2023) -
XV Reunión Post-ECTRIMS: revisión de las novedades presentadas en el Congreso ECTRIMS 2022 (I)
por: Fernández, Óscar, et al.
Publicado: (2023) -
EAN Perspective
por: Bassetti, C.
Publicado: (2021)